Overview Dividends

(BF-B) Brown-Forman - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1156372096

Whiskey, Bourbon, Tequila, Gin, Brandy

Distillers & Vintners
Market Cap in USD: 13,201m

IPO / Inception: 1984-09-07
Return 12m vs S&P 500: -40.2%

EPS (Earnings per Share)

EPS CAGR: -3.63%
EPS Trend: 5.0%

Last SUE: 0.00
Qual. Beats: 0

Revenue

Rev. CAGR: -0.03%
Rev. Trend: -38.3%

Last SUE: 0.42
Qual. Beats: 0

Dividends

Dividend Yield	3.39%
Yield on Cost 5y	1.28%
Yield CAGR 5y	5.84%
Payout Consistency	85.9%
Payout Ratio	53.3%

Risk via 5d forecast
Volatility	31.3%
Value at Risk 5%th	49.0%
Relative Tail Risk	-4.83%

Reward TTM
Sharpe Ratio	-0.89
Alpha	-45.03
CAGR/Max DD	-0.39

Character TTM
Hurst Exponent	0.574
Beta	0.570
Beta Downside	0.383

Drawdowns 3y
Max DD	62.30%
Mean DD	31.46%
Median DD	32.63%

Description: BF-B Brown-Forman October 30, 2025

Brown-Forman (NYSE: BF-B) is a global producer and marketer of alcoholic beverages, covering a portfolio that spans whiskey (Jack Daniel’s, Woodford Reserve, Old Forester, Gentleman Jack), tequila (Herradura, el Jimador), gin (Fords Gin), Scotch malt (The Glendronach, Benriach, Glenglassaugh), and a range of ready-to-drink and bottled-in-bond products. The firm also generates ancillary revenue from used-barrel sales, bulk whiskey and wine, and contract bottling services, distributing through a mix of independent distributors, state and provincial governments, and direct retail channels across North America, Europe, Asia-Pacific and Latin America.

Key recent metrics (FY 2023): net sales of approximately $4.5 billion, an operating margin of ~22 % and free cash flow of $1.1 billion, reflecting strong premium-segment pricing power. The company’s growth is driven by continued “premiumization” trends-U.S. consumers are allocating a higher share of discretionary spend to higher-priced spirits, while emerging-market demand for tequila and ready-to-drink cocktails is expanding. A material risk factor is the sensitivity of sales to macro-economic cycles and regulatory changes (e.g., excise tax adjustments), which can compress margins if consumer spending tightens.

For a deeper, data-driven look at how these dynamics translate into valuation outlook, you might explore the detailed analyst models on ValueRay.

Piotroski VR‑10 (Strict, 0-10) 5.5

Net Income (810.0m TTM) > 0 and > 6% of Revenue (6% = 233.3m TTM)

FCFTA 0.07 (>2.0%) and ΔFCFTA 1.92pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 71.87% (prev 64.80%; Δ 7.07pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.09 (>3.0%) and CFO 761.0m <= Net Income 810.0m (YES >=105%, WARN >=100%)

Net Debt (2.33b) to EBITDA (1.19b) ratio: 1.96 <= 3.0 (WARN <= 3.5)

Current Ratio 2.97 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (472.6m) change vs 12m ago -0.10% (target <= -2.0% for YES)

Gross Margin 59.12% (prev 59.21%; Δ -0.09pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 46.99% (prev 48.96%; Δ -1.97pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 7.72 (EBITDA TTM 1.19b / Interest Expense TTM 106.0m) >= 6 (WARN >= 3)

Altman Z'' 6.05

(A) 0.34 = (Total Current Assets 4.21b - Total Current Liabilities 1.42b) / Total Assets 8.22b

(B) 0.59 = Retained Earnings (Balance) 4.89b / Total Assets 8.22b

(D) 1.15 = Book Value of Equity 4.72b / Total Liabilities 4.09b

Total Rating: 6.05 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 61.44

1. Piotroski 5.50pt

2. FCF Yield 3.93%

3. FCF Margin 15.69%

4. Debt/Equity 0.64

5. Debt/Ebitda 1.96

6. ROIC - WACC (= 2.89)%

7. RoE 20.33%

8. Rev. Trend -38.28%

9. EPS Trend 5.02%

What is the price of BF-B shares?

As of December 25, 2025, the stock is trading at USD 26.89 with a total of 2,618,880 shares traded.
Over the past week, the price has changed by -6.76%, over one month by -5.08%, over three months by -1.95% and over the past year by -30.51%.

Is BF-B a buy, sell or hold?

Brown-Forman has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold BF-B.

Strong Buy: 2
Buy: 3
Hold: 10
Sell: 3
Strong Sell: 2

What are the forecasts/targets for the BF-B price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	30.6	13.9%
Analysts Target Price	30.6	13.9%
ValueRay Target Price	21.9	-18.5%

BF-B Fundamental Data Overview December 23, 2025

Market Cap USD = 13.20b (13.20b USD * 1.0 USD.USD)
P/E Trailing = 16.6667
P/E Forward = 17.301
P/S = 3.3946
P/B = 3.1934
P/EG = 5.1469
Beta = 0.403
Revenue TTM = 3.89b USD
EBIT TTM = 818.0m USD
EBITDA TTM = 1.19b USD
Long Term Debt = 2.07b USD (from longTermDebt, last quarter)
Short Term Debt = 575.0m USD (from shortTermDebt, last quarter)
Debt = 2.65b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.33b USD (from netDebt column, last quarter)
Enterprise Value = 15.53b USD (13.20b + Debt 2.65b - CCE 319.0m)
Interest Coverage Ratio = 7.72 (Ebit TTM 818.0m / Interest Expense TTM 106.0m)
FCF Yield = 3.93% (FCF TTM 610.0m / Enterprise Value 15.53b)
FCF Margin = 15.69% (FCF TTM 610.0m / Revenue TTM 3.89b)
Net Margin = 20.83% (Net Income TTM 810.0m / Revenue TTM 3.89b)
Gross Margin = 59.12% ((Revenue TTM 3.89b - Cost of Revenue TTM 1.59b) / Revenue TTM)
Gross Margin QoQ = 59.36% (prev 59.74%)
Tobins Q-Ratio = 1.89 (Enterprise Value 15.53b / Total Assets 8.22b)
Interest Expense / Debt = 0.87% (Interest Expense 23.0m / Debt 2.65b)
Taxrate = 19.71% (55.0m / 279.0m)
NOPAT = 656.7m (EBIT 818.0m * (1 - 19.71%))
Current Ratio = 2.97 (Total Current Assets 4.21b / Total Current Liabilities 1.42b)
Debt / Equity = 0.64 (Debt 2.65b / totalStockholderEquity, last quarter 4.13b)
Debt / EBITDA = 1.96 (Net Debt 2.33b / EBITDA 1.19b)
Debt / FCF = 3.82 (Net Debt 2.33b / FCF TTM 610.0m)
Total Stockholder Equity = 3.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.85% (Net Income 810.0m / Total Assets 8.22b)
RoE = 20.33% (Net Income TTM 810.0m / Total Stockholder Equity 3.98b)
RoCE = 13.51% (EBIT 818.0m / Capital Employed (Equity 3.98b + L.T.Debt 2.07b))
RoIC = 9.77% (NOPAT 656.7m / Invested Capital 6.72b)
WACC = 6.88% (E(13.20b)/V(15.85b) * Re(8.12%) + D(2.65b)/V(15.85b) * Rd(0.87%) * (1-Tc(0.20)))
Discount Rate = 8.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.78%
[DCF Debug] Terminal Value 77.76% ; FCFE base≈549.2m ; Y1≈539.3m ; Y5≈551.8m
Fair Price DCF = 32.80 (DCF Value 9.66b / Shares Outstanding 294.6m; 5y FCF grow -2.73% → 3.0% )
EPS Correlation: 5.02 | EPS CAGR: -3.63% | SUE: 0.0 | # QB: 0
Revenue Correlation: -38.28 | Revenue CAGR: -0.03% | SUE: 0.42 | # QB: 0
EPS next Quarter (2026-01-31): EPS=0.46 | Chg30d=-0.005 | Revisions Net=-2 | Analysts=13
EPS current Year (2026-04-30): EPS=1.64 | Chg30d=-0.000 | Revisions Net=-2 | Growth EPS=-11.1% | Growth Revenue=-3.4%
EPS next Year (2027-04-30): EPS=1.73 | Chg30d=+0.002 | Revisions Net=+1 | Growth EPS=+6.0% | Growth Revenue=+1.6%

Additional Sources for BF-B Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle